Three Drugs Equally Effective in Refractory Status Epilepticus
eMediNexus, 30 November 2019
remove_red_eye 638 Views
#Emergency Medicine #Neurology #Pharmacist
Coronavirus Live Count Map India
remove_red_eye 638 Views
Coronavirus Live Count Map World
#Emergency Medicine #Neurology #Pharmacist
Coronavirus FAQ PDF
Three drugs commonly used in the emergency department to treat patients with refractory status epilepticus were equally effective and safe, revealed the ESETT trial.
Each of the three medications -- levetiracetam (Keppra), fosphenytoin (Cerebyx), and valproate (Depacon) -- stopped seizures and improved responsiveness in about half of patients with benzodiazepine-refractory status epilepticus, reported researchers in the New England Journal of Medicine. Safety outcomes were similar for all three drugs.
To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Already registered?
.jpg)
Good information